- Home
- HSTM vs RGNX Comparison
HSTM vs RGNX Comparison
Compare HSTM & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSTM | RGNX |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 814.2M | 793.5M |
| IPO Year | 1999 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HSTM | RGNX |
|---|---|---|
| Price | $30.36 | $7.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $34.50 | $23.73 |
| AVG Volume (30 Days) | 143.7K | ★ 1.0M |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.47% | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $304,064,000.00 | $10,393,000.00 |
| Revenue This Year | $8.31 | N/A |
| Revenue Next Year | $4.59 | $29.31 |
| P/E Ratio | $69.41 | ★ N/A |
| Revenue Growth | 4.26 | ★ 126.48 |
| 52 Week Low | $19.50 | $5.46 |
| 52 Week High | $31.11 | $16.19 |
Technical Indicators
Market Signals| Indicator | HSTM | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 60.37 | 38.23 |
| Support Level | $27.77 | $7.12 |
| Resistance Level | $29.98 | $11.43 |
| Average True Range (ATR) | 0.64 | 0.44 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 70.29 | 29.14 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.